Given the fact that IGFBP3 suppression contributed to tumorigenesis and progression, here we determined the positive expression rate of IGFBP3, analyzed the role of IGFBP3 in treatment response and prognostic assessment of ABC-DLBCL, and further validated our results using the GEO database. This evidence concerns the gene IGFBP3 and aneurysmal bone cyst.